Literature DB >> 3305568

Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.

M A Mufson, R B Belshe, C Orvell, E Norrby.   

Abstract

Respiratory syncytial virus strains from 13 children who had repeat infections at least 1 year apart were identified as either subgroup A or subgroup B according to reaction patterns with several monoclonal antibodies directed against the large surface glycoprotein (G), fusion protein (F), nucleoprotein (NP), and matrix protein (M). The virus strains were characterized by enzyme immunoassay, polyacrylamide gel electrophoresis, and immunofluorescence procedures. During the first infection, 10 children had subgroup A strains and 3 had subgroup B strains. Of the 10 children with subgroup A strains during their first infection, 6 had subgroup B and 4 had subgroup A strains during the second infection. Of the three children with subgroup B strains during their first infection, one had subgroup A and two had subgroup B strains during their second infection. No child experienced unusually severe respiratory tract illnesses during second infections with respiratory syncytial virus. Fourfold or greater rises in serum antibody as determined by enzyme immunoassay were as common after the first infection as after the second infection among the seven children tested. Thus, second infections with strains of either subgroup of respiratory syncytial virus did not potentiate respiratory illness, and infection with subgroup A strains of respiratory syncytial virus provided some protection from a second infection with the homologous, but not the heterologous, subgroup of the virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305568      PMCID: PMC269264          DOI: 10.1128/jcm.25.8.1535-1539.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

Authors:  L J Anderson; J C Hierholzer; C Tsou; R M Hendry; B F Fernie; Y Stone; K McIntosh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

2.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

3.  Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.

Authors:  J Chin; R L Magoffin; L A Shearer; J H Schieble; E H Lennette
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

4.  Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus.

Authors:  H Sheshberadaran; S N Chen; E Norrby
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

5.  Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

Authors:  R A Olmsted; N Elango; G A Prince; B R Murphy; P R Johnson; B Moss; R M Chanock; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.

Authors:  C L Lamprecht; H E Krause; M A Mufson
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

7.  Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden.

Authors:  B Akerlind; E Norrby
Journal:  J Med Virol       Date:  1986-07       Impact factor: 2.327

8.  Structural differences between subtype A and B strains of respiratory syncytial virus.

Authors:  E Norrby; M A Mufson; H Sheshberadaran
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

9.  Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.

Authors:  R B Belshe; L P Van Voris; M A Mufson
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

10.  Monoclonal antibodies protect against respiratory syncytial virus infection in mice.

Authors:  G Taylor; E J Stott; M Bew; B F Fernie; P J Cote; A P Collins; M Hughes; J Jebbett
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

View more
  47 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Genetic and antigenic variability of human respiratory syncytial virus (groups a and b) isolated over seven consecutive seasons in Argentina (1995 to 2001).

Authors:  Monica C Galiano; Concepcion Palomo; Cristina M Videla; Juan Arbiza; José A Melero; Guadalupe Carballal
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Distinguishing between respiratory syncytial virus subgroups by protein profile analysis.

Authors:  P Walpita; M A Mufson; R J Stanek; D Pfeifer; J D Connor
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

4.  Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya.

Authors:  Paul D Scott; Rachel Ochola; Mwanajuma Ngama; Emelda A Okiro; D James Nokes; Graham F Medley; Patricia A Cane
Journal:  J Infect Dis       Date:  2005-11-17       Impact factor: 5.226

5.  Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.

Authors:  W M Sullender; M A Mufson; L J Anderson; G W Wertz
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  Genetic analysis and antigenic characterization of human respiratory syncytial virus group A viruses isolated in Germany 1996-2008.

Authors:  Ortwin Adams; Judith Werzmirzowsky; Hartmut Hengel
Journal:  Virus Genes       Date:  2013-06-18       Impact factor: 2.332

7.  The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.

Authors:  Lydia Tan; Frank E J Coenjaerts; Lieselot Houspie; Marco C Viveen; Grada M van Bleek; Emmanuel J H J Wiertz; Darren P Martin; Philippe Lemey
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

8.  Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.

Authors:  W B Coggins; E J Lefkowitz; W M Sullender
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 9.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

10.  Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells.

Authors:  Susana Infantes; Elena Lorente; Eilon Barnea; Ilan Beer; Juan José Cragnolini; Ruth García; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2010-01-15       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.